Abstract Details

Title MiR-218 as a candidate of biomarker for early diagnosis of ALS.

Topic General Neurology

Presentation(s) P1 - (-)

Poster/Presentation
Number 333

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Sandra Diaz Garcia, PhD (UC San Diego) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Samuel Pfaff, MD (Salk Institute for Biological Studies)	No disclosure on file
	No disclosure on file
John M. Ravits, MD, FAAN (University of California, San Diego)	Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.